Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| IKT (Inhibikase Therapeutics, Inc.) | -20.49% | -16.84% | -27.74% | -45.50% | NA | NA | NA | … | … |
Data as of 06/05/2026, Common starting date is 12/24/2020
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| IKT (Inhibikase Therapeutics, Inc.) | 12/24/2020 | 06/05/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | -6.86 | -16.84 | -27.74 | -45.50 | NA | NA | NA | … | … | -20.49 | -38.46 | 155.91 | -57.67 | -65.99 | -78.70 | -29.59 |
| Sharpe Ratio | NA | -0.26 | -0.25 | -0.48 | NA | NA | NA | … | … | -0.53 | -0.45 | 1.33 | -0.61 | -0.68 | -0.97 | -0.79 |
| Standard Deviation(%) | NA | 71.94 | 100.17 | 97.41 | NA | NA | NA | … | … | 65.81 | 92.43 | 112.16 | 101.92 | 99.55 | 81.56 | 126.20 |
| Draw Down(%) | NA | 32.21 | 81.25 | 97.81 | NA | NA | NA | … | … | 26.83 | 57.53 | 64.80 | 85.16 | 74.01 | 82.64 | 29.59 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/05/2026, Common starting date is 12/24/2020
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| IKT (Inhibikase Therapeutics, Inc.) |
-63.95%
Apr 2021 – Apr 2024 |
-48.13%
Jan 2021 – Jan 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| IKT (Inhibikase Therapeutics, Inc.) |
-11.92%
Dec 2022 – Dec 2025 |
-42.99%
Apr 2021 – Apr 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart